β€’
Sep 30, 2022

Northrop Grumman Q3 2022 Earnings Report

Northrop Grumman's Q3 2022 financial results were reported, with sales increasing and EPS impacted by marketable securities.

Key Takeaways

Northrop Grumman reported a 3% increase in sales to $9.0 billion for Q3 2022 compared to $8.7 billion in Q3 2021. Diluted EPS was $5.89, which included a $0.18 unfavorable impact from marketable securities. The company reaffirmed its 2022 guidance for sales, EPS, and transaction-adjusted free cash flow.

Awards totaled $8.7 billion, resulting in a book-to-bill ratio of 0.97 for the quarter and 1.14 year-to-date.

Sales increased by 3 percent, reaching $9.0 billion.

Diluted EPS was $5.89, including a $0.18 unfavorable impact from marketable securities.

Net cash provided by operating activities amounted to $1.3 billion.

Total Revenue
$8.97B
Previous year: $8.72B
+2.9%
EPS
$5.89
Previous year: $6.63
-11.2%
Total Backlog
$79.6B
Previous year: $74.8B
+6.4%
Gross Profit
$1.82B
Previous year: $1.93B
-6.0%
Cash and Equivalents
$1.67B
Previous year: $4.06B
-58.9%
Free Cash Flow
$1.04B
Previous year: $916M
+13.4%
Total Assets
$42.7B
Previous year: $42.3B
+0.9%

Northrop Grumman

Northrop Grumman

Northrop Grumman Revenue by Segment

Forward Guidance

The company expects 2022 sales and diluted earnings per share near the low end of our guidance ranges of approximately $36.2 β€” $36.6 billion and $24.50 β€” $25.10, respectively. We continue to expect transaction-adjusted free cash flow1 of $1.5 β€” $1.8 billion based on current tax law, which requires the amortization of current year research and development expenditures over five years.

Revenue & Expenses

Visualization of income flow from segment revenue to net income